A carregar...
The coxibs and traditional nonsteroidal anti-inflammatory drugs: A current perspective on cardiovascular risks
There is strong evidence from randomized clinical trials that the highly selective cox-2 inhibitors (coxibs), compared with placebo, cause an excess of serious cardiovascular events that are not mitigated by low-dose acetylsalicylic acid. Both Health Canada and the Food and Drug Administration have...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pulsus Group Inc
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2650648/ https://ncbi.nlm.nih.gov/pubmed/17311118 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|